Millennium Management’s Titan Pharmaceuticals TTNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-756
Closed -$6.23K 6668
2023
Q4
$6.23K Buy
+756
New +$5.63K ﹤0.01% 5792
2022
Q4
Sell
-873
Closed -$19K 7065
2022
Q3
$19K Sell
873
-2,282
-72% -$58.9K ﹤0.01% 6476
2022
Q2
$35K Buy
3,155
+2,643
+516% +$33K ﹤0.01% 6312
2022
Q1
$10K Sell
512
-497
-49% -$10.3K ﹤0.01% 6736
2021
Q4
$21K Buy
+1,009
New +$30.4K ﹤0.01% 6599
2021
Q2
Sell
-844
Closed -$50K 7119
2021
Q1
$50K Buy
+844
New +$55.9K ﹤0.01% 5774
2018
Q3
Sell
-12
Closed -$48K 4289
2018
Q2
$48K Sell
12
-13
-52% -$43.5K ﹤0.01% 3707
2018
Q1
$95K Sell
25
-10
-29% -$41.8K ﹤0.01% 3484
2017
Q4
$169K Sell
35
-26
-43% -$162K ﹤0.01% 3567
2017
Q3
$382K Sell
61
-3
-5% -$18.6K ﹤0.01% 2964
2017
Q2
$437K Buy
+64
New +$595K ﹤0.01% 2870
2016
Q4
Sell
-7
Closed -$146K 3747
2016
Q3
$146K Buy
+7
New +$136K ﹤0.01% 3059
2016
Q1
Sell
-17
Closed -$277K 3665
2015
Q4
$277K Buy
+17
New +$277K ﹤0.01% 2936

Other funds holding TTNP

Millennium Management's TTNP Position: Q1 2024 in Review

Millennium Management sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 756 shares — an estimated $6.23K sold.

Millennium Management first reported a position in TTNP in Q4 2015 and held it in 13 quarters. The position peaked at $437K in Q2 2017. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.

  • Millennium Management reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 756 Titan Pharmaceuticals shares in Q1 2024, an estimated $6.23K.
  • Millennium Management first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 13 quarters.
  • Millennium Management's Titan Pharmaceuticals position peaked at $437K in Q2 2017.
  • 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.